Mehul Shah
About Mehul Shah
Mehul Shah is the Executive Director of Oncology, Hematology, and Cell Therapy Business Development Transactions at Bristol Myers Squibb, and an Investment Screening Committee Member at Delaware Crossing Angel Investor Group.
Company
Mehul Shah currently holds a pivotal role at Bristol Myers Squibb, working as the Executive Director of Oncology, Hematology, and Cell Therapy Business Development Transactions. His position is based in Princeton, New Jersey, within the United States.
Title
Mehul Shah is the Executive Director of Oncology, Hematology, and Cell Therapy Business Development Transactions at Bristol Myers Squibb. His responsibilities include identifying, evaluating, and negotiating strategic opportunities that align with the company's vision and portfolio strategy in these therapeutic areas.
Education and Expertise
Mehul Shah possesses a strong educational background, having studied at the University of the Sciences in Philadelphia where he earned both a Bachelor of Science in Pharmacy and a Doctor of Pharmacy (PharmD). He furthered his education with an Executive MBA in Pharmaceutical Marketing and Management from Saint Joseph's University – Erivan K. Haub School of Business. Additionally, he has an Executive Education Professional Development Certificate from The Wharton School. With over 20 years of experience in the pharmaceutical and biotech industry, he specializes in business development, commercial assessment, and deal structuring.
Professional Background
Before his current role at Bristol Myers Squibb, Mehul Shah held significant positions in other major pharmaceutical and biotech companies. He worked at Pfizer as Senior Director of Business Development and Commercial Assessment from 2015 to 2021 in New York. Prior to Pfizer, he served as Director of Corporate Business Development at Endo International plc from 2010 to 2014 and as Director of Strategic Marketing from 2008 to 2010. His earlier career includes roles at Wyeth Biotech, where he was Director of Hemophilia Marketing in 2007 and Director of Neuroscience New Business in 2006.
Achievements in Business Development
Throughout his career, Mehul Shah has successfully led and executed multiple transactions across various therapeutic areas, including oncology, vaccines, rare disease, and neuroscience. His expertise is reflected in his ability to leverage his educational background and extensive network to conduct thorough due diligence and develop compelling business cases. His work aims to support innovation and entrepreneurship that can improve patients' lives and transform healthcare.